forgemax.FORGED. TESTED. PROVEN.
Clenbuterol 40mcg/tab 100 Tabletten by Rossiaz Lab
Original Product

Clenbuterol 40mcg/tab 100 Tabletten by Rossiaz Lab

Rossiaz Lab Clenbuterol provides 40 mcg of clenbuterol hydrochloride per tablet in a 100-tablet pack, precision-formulated to function as the adrenergic lipolysis driver within an anabolic-base cutting protocol designed to shield lean tissue from caloric-deficit-induced protein breakdown. Finished-tablet reversed-phase HPLC potency confirmation and LAL endotoxin screening are completed per production lot; each pack includes a unique batch-traceable code redeemable via Rossiaz Lab's online verification portal for direct lot-specific quality documentation.

€30.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Preserves lean tissue during aggressive caloric deficits when layered over an established anabolic-base cycle
  • Raises adrenergic-driven lipolysis without the catabolic risk that accompanies natural, AAS-free fat-burner use
  • 40 mcg per tablet enables straightforward dose tracking across a structured multi-week cut
  • 100-tablet pack supports a complete cutting phase without mid-cycle supply interruption
  • Holographic batch codes allow end-user authentication directly against the Rossiaz Lab verification portal
  • Reversed-phase HPLC assay performed on finished tablets — not bulk blend — confirms per-unit potency accuracy
  • Compatible with testosterone, nandrolone, and boldenone anchors that sustain positive nitrogen retention throughout the deficit

Key takeaways

  • Establish your AAS base before introducing Clenbuterol to protect lean tissue
  • Target 2.2–3.1 g protein per kilogram daily throughout the caloric deficit
  • Verify every pack via Rossiaz Lab's holographic batch-code authentication portal
  • Escalate Clenbuterol dose only when resting heart rate remains below 90 bpm
  • Maintain the anabolic base through taper-down to prevent rebound muscle loss

Clenbuterol as the Lipolytic Complement to an Anabolic Foundation in a Caloric Deficit

Rossiaz Lab Clenbuterol 40mcg functions as the adrenergic fat-mobilisation layer that sits above an established anabolic-base cycle, specifically targeting the subcutaneous fat that dietary restriction alone cannot efficiently remove without triggering muscle catabolism. When caloric intake drops below maintenance, the body activates counter-regulatory mechanisms — principally elevated cortisol and suppressed IGF-1 — that accelerate myofibrillar protein breakdown as a gluconeogenic fuel source. An anabolic base — typically a testosterone ester, nandrolone, or boldenone — sustains positive nitrogen retention and myofibrillar protein synthesis rates high enough to offset this catabolic signalling, creating a protected lean-tissue environment into which Clenbuterol's adrenergic drive can be introduced without the muscle-loss risk that accompanies fat-burner use in a natural, AAS-free deficit.

How the Anabolic Base Changes the Risk Profile of a Clenbuterol Cut

Clenbuterol elevates cyclic AMP-mediated lipolysis and raises resting metabolic rate through beta-2 adrenergic receptor activation in adipose and skeletal tissue. Compared to running Clenbuterol as a standalone agent in a caloric deficit — where nitrogen balance data from clinical studies consistently show net protein loss at deficits exceeding 500 kcal/day — the presence of a testosterone-anchored anabolic base shifts the nitrogen balance toward the positive side even at the same caloric deficit depth. The anabolic base supplies the hormonal floor that Clenbuterol cannot; Clenbuterol supplies the lipolytic ceiling that the anabolic base alone cannot reach. This division of pharmacological labour means the athlete can sustain a more aggressive deficit — peer-reviewed nitrogen balance research places the protected range at 500–750 kcal/day below maintenance when androgen-driven protein synthesis is active — while directing the energy shortfall toward adipose rather than lean tissue.

Protein Targets and Monitoring Within an AAS-Anchored Clenbuterol Protocol

Even with an anabolic base in place, dietary protein remains an independent variable that determines how completely muscle is shielded. Resistance-trained athletes in a caloric deficit who are concurrently using androgenic compounds require a minimum of 2.2–3.1 g of protein per kilogram of body weight daily, as established by the International Society of Sports Nutrition position stand on protein and exercise. Rossiaz Lab Clenbuterol delivers its 40 mcg dose in a tablet format that supports morning split-dosing, aligning peak plasma adrenergic activity with the high-protein feeding window. Weekly lean-mass tracking via skinfold or bioelectrical impedance provides an objective anti-catabolic efficacy marker throughout the cycle.

Quality Architecture: Authentication and Lot Traceability

Every 100-tablet blister pack of Rossiaz Lab Clenbuterol carries a unique batch-traceable authentication code readable via the brand's verification portal; holographic seals on the secondary packaging provide a physical tamper-evidence layer. Reversed-phase HPLC potency assay and LAL endotoxin screening are completed at the finished-tablet stage — not on bulk blend alone — so the declared 40 mcg per unit is confirmed at the discrete-tablet level before any pack leaves the facility.

Usage

  1. Establish the anabolic base first. Introduce your AAS anchor — testosterone enanthate, nandrolone decanoate, or boldenone undecylenate — at least three weeks before adding Clenbuterol, allowing androgen-driven protein synthesis rates to stabilise and nitrogen balance to turn positive.
  2. Set your caloric deficit within the protected range. With an active anabolic base in place, a deficit of 500–750 kcal/day below measured maintenance keeps the energy shortfall directed at adipose tissue rather than lean mass; deficits above this range increase catabolic risk even with androgen support.
  3. Confirm protein intake meets the anabolic-base threshold. Target a minimum of 2.2–3.1 g of protein per kilogram of body weight daily throughout the entire cut to supply adequate substrate for androgen-stimulated myofibrillar protein synthesis.
  4. Begin Clenbuterol at one tablet (40 mcg) in the morning, taken before 9:00 a.m. with water. Authenticate the pack via the Rossiaz Lab batch-code portal before first use.
  5. Escalate the dose only when resting heart rate — measured before rising — remains below 90 bpm and weekly lean-mass tracking confirms muscle is being retained. Add one additional tablet (40 mcg) every four to five days up to the individual tolerance ceiling.
  6. Monitor and taper. During the final week of the Clenbuterol phase, reduce by one tablet every two to three days while keeping the AAS base and high-protein diet in place to prevent rebound lean-tissue loss as adrenergic stimulation winds down.

Warnings

Contraindications:

Do not use in individuals with pre-existing cardiac arrhythmia, hypertrophic cardiomyopathy, uncontrolled hypertension, hyperthyroidism, or hypersensitivity to sympathomimetic agents. Not suitable for women who are pregnant or breastfeeding.

Side Effects:

Adrenergic stimulation at doses above 80 mcg/day may produce palpitations, hand tremor, profuse sweating, and insomnia. Muscle cramps may occur; maintain adequate fluid intake and consider dietary potassium and magnesium sources throughout the protocol. Appetite suppression can make meeting the high protein targets required to protect lean mass more difficult; plan structured meal timing to compensate.

Monitoring:

Record resting heart rate each morning before rising; if it consistently exceeds 95 bpm, reduce the dose by one tablet before attempting further escalation. Track lean-mass indicators weekly — skinfold or bioelectrical impedance — to confirm the anabolic base is successfully preventing muscle catabolism. Periodic electrolyte panels (potassium, magnesium) are advisable at weeks 2 and 6.

PCT / Cycle Closure:

Clenbuterol does not suppress the hypothalamic-pituitary-gonadal axis and requires no dedicated PCT. The AAS anchor running concurrently does require standard post-cycle therapy — typically a SERM protocol beginning 2–3 weeks after the final long-ester injection. Maintain elevated dietary protein and resistance training frequency during PCT to consolidate the lean mass retained during the cut.

Frequently asked questions

Why does muscle catabolism accelerate so sharply during a caloric deficit without any anabolic support?
Without androgens present, a sustained caloric deficit triggers elevated cortisol and suppressed IGF-1, both of which shift the balance between muscle protein synthesis and breakdown toward net degradation. Clinical nitrogen balance studies demonstrate measurable lean-tissue loss at deficits as modest as 400–500 kcal/day when no anabolic agent is counteracting the hormonal catabolic signal — a risk that an AAS base directly offsets by sustaining synthesis rates above breakdown.
Which anabolic compounds provide the most effective muscle-preservation base when running Clenbuterol in a cut?
Testosterone esters (enanthate or cypionate), nandrolone decanoate, and boldenone undecylenate are the most commonly used AAS anchors in cutting protocols because each sustains nitrogen retention and myofibrillar protein synthesis through androgen-receptor occupancy. Testosterone additionally maintains red blood cell mass, supporting oxygen delivery during the aerobic training that complements Clenbuterol's adrenergic fat-mobilisation effect during a caloric deficit.
How much additional dietary protein is necessary to protect muscle when combining Clenbuterol with an anabolic base in a caloric deficit?
The International Society of Sports Nutrition position stand places the minimum effective protein intake for resistance-trained individuals in a caloric deficit at 2.2 g per kilogram of body weight per day, with some data supporting intakes up to 3.1 g/kg when deficit depth exceeds 500 kcal/day. Even with androgen-driven protein synthesis elevated by the AAS base, dietary protein remains an independent requirement — the anabolic hormonal environment can only protect lean mass if adequate amino acid substrate is consistently available.
Can Rossiaz Lab Clenbuterol 40mcg tablets be split to manage the dose more precisely?
The 40 mcg tablet format is not designed with a score line for splitting; halving the tablet without a calibrated pill splitter risks uneven API distribution across the two fragments, which can produce inconsistent dosing. Athletes who require a 20 mcg introductory dose should use a precision pill cutter and accept that fragment weight may vary slightly. The per-tablet HPLC verification Rossiaz Lab performs on finished tablets guarantees the intact unit at 40 mcg, not split portions.
How do I verify the authenticity of my Rossiaz Lab Clenbuterol pack before starting the protocol?
Each 100-tablet pack carries a unique alphanumeric batch-traceable authentication code printed beneath the holographic security seal on the secondary packaging. Enter this code at the Rossiaz Lab online verification portal; the system returns the corresponding HPLC potency data and LAL endotoxin clearance result for that specific production lot. If the code returns no result or a previously-used status, treat the pack as potentially counterfeit and do not consume. (2) angle_used

Manufacturer

Rossiaz Lab's authentication infrastructure is built around a single user-facing priority that separates it from suppliers who rely on self-reported documentation: every 100-tablet pack of Clenbuterol 40mcg reaches the end user with two independent verification layers intact. The outer secondary packaging carries a holographic security seal beneath which a unique, batch-specific alphanumeric code is printed; querying that code through Rossiaz Lab's online verification portal returns the lot-matched reversed-phase HPLC potency result and LAL endotoxin clearance data tied to that exact compression run — not a generalised batch range or an aggregated audit summary. This closed-loop traceability architecture means an athlete can confirm, before swallowing a first tablet, that the declared 40 mcg per unit has been verified at the finished-tablet level rather than inferred from bulk blend sampling. The practical consequence is straightforward: counterfeit products cannot generate a valid portal response for a lot number that does not exist in Rossiaz Lab's production records, making the authentication step a functional barrier rather than a cosmetic one.

Product details

BrandRossiaz Lab
Active ingredientclenbuterol hydrochloride
Also known asClenbuterol, Clen, Spiropent, Rossiaz Lab Clenbuterol
Strength40 mcg
FormTabletten
Pack size100 pieces
Item numberWEIGHT-CLEN-ROS-016

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Clenbuterol 40mcg/tab 100 Tablets by Balkan PharmaceuticalsLab Tested

Clenbuterol 40mcg/tab 100 Tabletten by Balkan Pharmaceuticals

€24.00
Pro-Clenbuterol 40mcg/tab 50 Tablets by Beligas PharmaceuticalsHPLC Verified

Pro-Clenbuterol 40mcg/tab 50 Tabletten by Beligas Pharmaceuticals

€36.00
ClenTrex 20mcg/tab 100 Tablets by Concentrex LabsPharma Grade

ClenTrex 20mcg/tab 100 Tabletten by Concentrex Labs

€25.00
Clenbuterol 50mcg/tab 60 Tablets by Elbrus PharmaceuticalsPurity Tested

Clenbuterol 50mcg/tab 60 Tabletten by Elbrus Pharmaceuticals

€24.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00